The Discounted Cash Flow (DCF) valuation of Lee Pharmaceuticals (LPHM) is 0.00 USD. With the latest stock price at 0.07 USD, the upside of Lee Pharmaceuticals based on DCF is -97.3%.
Based on the latest price of 0.07 USD and our DCF valuation, Lee Pharmaceuticals (LPHM) is a sell. selling LPHM stocks now will result in a potential gain of 97.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.2% | 6.3% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | (0.01) - 0.03 | 0.00 |
| Upside | -107.7% - -58.1% | -97.3% |